Jeremy McDowell, PA
Medical · Fitchburg, MANPI 1730700220
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 180 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 23.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,838 and has fallen 92.7% since, to $134 in 2024. Among medical clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 180 payments — averaging $21.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$905
- Lilly USA, LLC$558
- AbbVie$409
- Amgen$279
- Neurocrine Biosciences, Inc.$239
- Novo Nordisk$187
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,917100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 35 | $905 |
| Lilly USA, LLC | 25 | $558 |
| AbbVie | 21 | $409 |
| Amgen | 16 | $279 |
| Neurocrine Biosciences, Inc. | 10 | $239 |
| Novo Nordisk | 9 | $187 |
| Boehringer Ingelheim | 8 | $165 |
| Otsuka America Pharmaceutical, Inc. | 7 | $153 |
| Bayer | 5 | $113 |
| Philips North America LLC | 6 | $108 |
| E.r. Squibb & Sons, L.L.C. | 5 | $103 |
| Daiichi Sankyo Inc. | 4 | $82 |
| Abbott | 4 | $80 |
| CMP Pharma, Inc. | 3 | $68 |
| GSK | 3 | $64 |
| Esperion Therapeutics, Inc. | 3 | $54 |
| Biogen | 2 | $44 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $42 |
| Lundbeck LLC | 2 | $41 |
| Astellas Pharma US Inc | 2 | $39 |
| Johnson & Johnson | 1 | $38 |
| Acadia Pharmaceuticals Inc | 1 | $25 |
| Qiagen, LLC | 1 | $23 |
| Medtronic | 1 | $22 |
| Almatica Pharma LLC | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Pfizer | 1 | $13 |
How this compares
$3,917 in reported general payments places this provider in the 90th percentile of 421 medical providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 38 | $12,581 |
| Mirtazapine | 171 | $1,863 |
| Memantine Hcl | 20 | $1,053 |
| Amiodarone Hcl | 27 | $935 |
| Aripiprazole | 35 | $851 |
| Furosemide | 125 | $837 |
| Atorvastatin Calcium | 90 | $684 |
| Levothyroxine Sodium | 65 | $631 |
| Lorazepam | 38 | $607 |
| Duloxetine Hcl | 53 | $563 |
| Oseltamivir Phosphate | 13 | $529 |
| Omeprazole | 38 | $494 |
| Gabapentin | 39 | $438 |
| Pregabalin | 18 | $431 |
| Tramadol Hcl | 50 | $376 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $13 | $12,58138 claims |
| Lilly USA, LLCOlanzapine | $558 | $30429 claims |
| Almatica Pharma LLCSertraline Hcl | $22 | $28955 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 421 medical providers in Massachusetts.
Other medical in Fitchburg
- Eileen CheeverLeominster$389K
- Vidal PrimiterioLawrence$22K
- Michelle BaytarianJamaica Plain$17K
- Julia FioreAgawam$16K
- Jennifer LevesqueFall River$15K
- Ashley HoffmanWestfield$13K
- Theresa FukudaBoston$13K
- Christina MessingerPlymouth$11K
- Lauren CarraSpringfield$9K
- Raul AliceaSpringfield$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.